Literature DB >> 20066425

Lag time between onset of symptoms and diagnosis in Venezuelan patients with rheumatoid arthritis.

Elaudi Rodríguez-Polanco1, Soham Al Snih, Yong-Fang Kuo, Alberto Millán, Martín A Rodríguez.   

Abstract

A retrospective study in a hospital-based sample of Venezuelan patients with rheumatoid arthritis was made to estimate the lag time between onset of symptoms, diagnosis, and initiation of DMARD treatment. Medical records and in-person interview of patients to fill in a questionnaire collecting information on demographics and initiation of symptoms, first consultation with any physician, time of diagnosis, and initiation of first disease-modifying anti-rheumatic drug were reviewed. We performed descriptive statistics and multivariable linear regression analysis. Mean lag time between symptom onset and diagnosis of rheumatoid arthritis was 40.5 months (range 1-424). Mean lag time between onset of symptoms and first consultation with a physician and between first consultation and diagnosis was 16.3 and 23.9 months, respectively. Mean lag time between onset of symptoms and initiation of DMARD treatment was 56.9 months. A definitive diagnosis of rheumatoid arthritis was done by a rheumatologist in 251 patients (92.3%). First consultation with an orthopedist or a primary care physician, first consultation in a public versus a private health center, and diagnosis before 2000 were associated with longer lag time between onset of symptoms and diagnosis. Venezuelan patients with rheumatoid arthritis had a marked delay from disease onset to diagnosis and initiation of first DMARD. First consultation with an orthopedist and consultation in a public versus a private health center were the variables with the strongest effect on lag time to diagnosis and to initiation of first DMARD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20066425     DOI: 10.1007/s00296-009-1358-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  28 in total

1.  Guidelines for the management of rheumatoid arthritis: 2002 Update.

Authors: 
Journal:  Arthritis Rheum       Date:  2002-02

2.  Clinical expression of rheumatoid arthritis in Chilean patients.

Authors:  L Massardo; V Aguirre; M E García; V Cervila; S Nicovani; A González; S Rivero; S Jacobelli
Journal:  Semin Arthritis Rheum       Date:  1995-12       Impact factor: 5.532

3.  [Criterios utilizados por médicos de atención primaria para el diagnóstico y derivación al reumatólogo del paciente con artritis reumatoide].

Authors:  Daniel Xibillé-Friedmann; Victor Mondragón-Flores; César Horcasitas de la Rosa
Journal:  Reumatol Clin       Date:  2008-12-10

4.  Rheumatology referral patterns.

Authors:  R S Hooker; J B Brown
Journal:  HMO Pract       Date:  1990 Mar-Apr

5.  Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice.

Authors:  S Irvine; R Munro; D Porter
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

Review 6.  Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide.

Authors:  P Emery; F C Breedveld; M Dougados; J R Kalden; M H Schiff; J S Smolen
Journal:  Ann Rheum Dis       Date:  2002-04       Impact factor: 19.103

7.  Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care.

Authors:  I E van der Horst-Bruinsma; I Speyer; H Visser; F C Breedveld; J M Hazes
Journal:  Br J Rheumatol       Date:  1998-10

8.  Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study.

Authors:  C Egsmose; B Lund; G Borg; H Pettersson; E Berg; U Brodin; L Trang
Journal:  J Rheumatol       Date:  1995-12       Impact factor: 4.666

Review 9.  Joint erosions and patients with early rheumatoid arthritis.

Authors:  D M van der Heijde
Journal:  Br J Rheumatol       Date:  1995-11

10.  The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial.

Authors:  A van der Heide; J W Jacobs; J W Bijlsma; A H Heurkens; C van Booma-Frankfort; M J van der Veen; H C Haanen; D M Hofman; G A van Albada-Kuipers; E J ter Borg; H L Brus; H J Dinant; A A Kruize; Y Schenk
Journal:  Ann Intern Med       Date:  1996-04-15       Impact factor: 25.391

View more
  15 in total

1.  Rheumatoid arthritis in the indigenous qom population of Rosario, Argentina: aggressive and disabling disease with inadequate adherence to treatment in a community-based cohort study.

Authors:  Rosana Quintana; Mario Goñi; Nora Mathern; Marisa Jorfen; Silvana Conti; Romina Nieto; Alvaro Sanabria; Cristina Prigione; Adriana M R Silvestre; Vanina García; Guillermo Pons-Estel; Ricard Cervera; Conrado García; Ingris Peláez-Ballestas; Graciela S Alarcón; Bernardo A Pons-Estel
Journal:  Clin Rheumatol       Date:  2018-04-19       Impact factor: 2.980

2.  Clinical patterns and characteristics of ankylosing spondylitis in China.

Authors:  Qiaoxia Qian; Xia Xu; Hongjun He; Hengdong Ji; Hui Zhang; Yue Ding; Sheng-Ming Dai; Yaohong Zou; Qi Zhu; Chengde Yang; Shuang Ye; Lindi Jiang; Jian-Ping Tang; Qiang Tong; Dongyi He; Dongbao Zhao; Yuan Li; Yanyun Ma; Jingru Zhou; Ziyu Yuan; Juan Zhang; Li Jin; Xiaodong Zhou; John D Reveille; Hejian Zou; Jiucun Wang
Journal:  Clin Rheumatol       Date:  2017-05-27       Impact factor: 2.980

3.  Factors associated with time to diagnosis in early rheumatoid arthritis.

Authors:  Cheryl Barnabe; Juan Xiong; Janet E Pope; Gilles Boire; Carol Hitchon; Boulos Haraoui; J Carter Thorne; Diane Tin; Edward C Keystone; Vivian P Bykerk
Journal:  Rheumatol Int       Date:  2013-08-30       Impact factor: 2.631

4.  From Symptoms to Diagnosis: An Observational Study of the Journey of Rheumatoid Arthritis Patients in Saudi Arabia.

Authors:  Waleed Hussain; Abdulsalam Noorwali; Nahid Janoudi; Maatouqa Baamer; Lina Kebbi; Hanady Mansafi; Ashraf Ibrahim; Shereen Gohary; Joan Minguet; Hani Almoallim
Journal:  Oman Med J       Date:  2016-01

5.  Does healthcare regime affiliation influence the clinical outcomes of patients with rheumatoid arthritis?

Authors:  Julián E Barahona-Correa; Jorge Flórez-Suárez; Paola Coral-Alvarado; Paul Méndez-Patarroyo; Gerardo Quintana-López
Journal:  Clin Rheumatol       Date:  2020-08-19       Impact factor: 2.980

6.  General practitioners' perspectives on campaigns to promote rapid help-seeking behaviour at the onset of rheumatoid arthritis.

Authors:  Rebecca J Stack; Zara Llewellyn; Chris Deighton; Patrick Kiely; Christian D Mallen; Karim Raza
Journal:  Scand J Prim Health Care       Date:  2014-03       Impact factor: 2.581

Review 7.  Help-seeking trajectory in patients with rheumatoid arthritis.

Authors:  Ingris Pelaez; Claudia Infante; Rosana Quintana
Journal:  Clin Rheumatol       Date:  2015-07-23       Impact factor: 2.980

Review 8.  Access to an optimal treatment. Current situation.

Authors:  Manuel F Ugarte-Gil; Adriana M R Silvestre; Bernardo A Pons-Estel
Journal:  Clin Rheumatol       Date:  2015-07-19       Impact factor: 2.980

Review 9.  The journey of rheumatoid arthritis patients: a review of reported lag times from the onset of symptoms.

Authors:  Alaa S Barhamain; Rami F Magliah; Mohammad H Shaheen; Shurooq F Munassar; Ayman M Falemban; Mohammed M Alshareef; Hani M Almoallim
Journal:  Open Access Rheumatol       Date:  2017-07-28

10.  Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry.

Authors:  Jan Sørensen; Merete Lund Hetland
Journal:  Ann Rheum Dis       Date:  2014-02-17       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.